Metagenomi, Inc. (MGX) Sotuvning operatsion marjasi

metagenomi.co (MGX) grafik logotipi

Geopolitik keskinliklar va sanksiyalar Metagenomi, Inc. (MGX) kompaniyasiga global genetik arxivlardan foydalanish imkoniyatini cheklamoqda. Moslashtirilgan operatsion marja kunlik foyda dinamikasini shaffof ko'rsatadi, bunda -1410.60 eng so'nggi metrika qiymatini aks ettiradi. Biznesning o'sishi sog'liqni saqlash gigantlari bilan strategik ittifoqlarga asoslangan, barqarorlik esa resurslar yetishmovchiligini bartaraf etuvchi diversifikatsiyalashgan biokomponent ta'minot zanjirlari orqali ta'minlanadi.

metagenomi.co (MGX): Sotuvning operatsion marjasi 21.02.2024dan 20.11.2026gacha

Metagenomi, Inc. (MGX) kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:MGX, Metagenomi, Inc.
Metagenomi Therapeutics brendining mahsuloti

Ushbu ko'rsatkich operatsion foydaning umumiy daromadga nisbatini o'lchaydi, bu esa qarz yuklamasi va soliqlarni hisobga olishdan oldin biznes modelining samaradorligini baholash imkonini beradi. Metagenomi, Inc. (MGX) kompaniyasining asosiy operatsion marjlaridagi salbiy tendentsiya kutilgan holdir, chunki tijorat mahsulotlarining yo'qligi va ventura kapitali oluqlariga bog'liqlik genom tahrirlash tizimini ishlab chiqishning joriy bosqichida ichki pul oqimini yaratishni imkonsiz qiladi.

Raqobatdosh kompaniyalar

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik